Skip to main content

CINQAIR

NDC 59310-610 · Teva Respiratory, LLC

Generic nameReslizumab
Dosage formINJECTION, SOLUTION, CONCENTRATE
RouteINTRAVENOUS
Active ingredient(s)RESLIZUMAB
Strength10 mg/mL
Pharmacologic classInterleukin-5 Antagonist [EPC], Interleukin-5 Antagonists [MoA]
Marketing categoryBLA

Packages

59310-610-31 — 1 VIAL, SINGLE-USE in 1 CARTON (59310-610-31) / 10 mL in 1 VIAL, SINGLE-USE

Billed under HCPCS

J2786 — Injection, reslizumab, 1 mg Medicare Part B payment limit (ASP + 6%): $11.73

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.